ABT Operating Cash Flow (Statement)

Abbott Laboratories · Operating Cash Flow (Statement)

ABT logo

ABT Operating Cash Flow (Statement)

Latest reported$2.49B
ABT Quarterly Cash from Operations ($217.50M → $2.49B)
High-resolution chart · PNG

ABT operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
2,488,000,000
1,315,000,000
3,315,000,000
2,787,000,000
2,047,000,000
1,417,000,000
2,868,000,000
2,705,000,000
1,960,000,000
1,025,000,000
3,038,000,000
1,877,000,000
1,203,000,000
1,143,000,000
2,326,000,000
2,780,000,000
2,410,000,000
2,065,000,000
3,067,000,000
2,701,000,000
2,128,000,000
2,637,000,000
3,798,000,000
2,066,000,000
1,322,000,000
715,000,000
2,416,000,000
1,948,000,000
1,060,000,000
712,000,000
1,765,000,000
2,183,000,000
1,244,000,000
1,108,000,000
1,640,000,000
2,005,000,000
1,351,000,000
574,000,000
1,170,000,000
1,217,000,000
909,000,000
-93,000,000
828,000,000
1,195,000,000
941,000,000
2,000,000
1,238,000,000
1,201,000,000
900,000,000
336,000,000
1,625,061,000
522,125,000
716,559,000
460,255,000
1,503,140,000
3,519,502,000
2,066,829,000
2,224,930,000
1,401,349,000
3,054,430,000
2,503,152,000
2,011,146,000
2,316,519,000
2,548,413,000
2,348,297,000
1,522,752,000
1,832,617,000
3,030,024,000
1,713,801,000
698,718,000
1,582,154,000
2,698,411,000
1,758,475,000
1,305,151,000
1,050,091,000
1,538,010,000
1,539,455,000
1,056,287,000
1,288,543,000
1,284,889,000
1,572,690,000
1,183,119,000
1,351,248,000
1,424,911,000
1,864,530,000
533,727,000
802,603,000
865,782,000
1,384,216,000
1,355,342,000
646,728,000
1,089,042,000
1,067,662,000
943,016,000
1,199,529,000
900,933,000
918,869,000
1,163,613,000
887,390,000
1,184,378,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.